Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171.

MLA

Xiang, Ruiqing, et al. “Discovery of a High Potent PIM Kinase Inhibitor for Acute Myeloid Leukemia Based on N-Pyridinyl Amide Scaffold by Optimizing the Fragments toward to Lys67 and Asp128/Glu171.” European Journal of Medicinal Chemistry, vol. 257, Sept. 2023, p. 115514. EBSCOhost, https://doi.org/10.1016/j.ejmech.2023.115514.

APA

Xiang, R., Lu, M., Wu, T., Yang, C., Jia, Y., Liu, X., Deng, M., Ge, Y., Xu, J., Cai, T., Ling, Y., & Zhou, Y. (2023). Discovery of a high potent PIM kinase inhibitor for acute myeloid leukemia based on N-pyridinyl amide scaffold by optimizing the fragments toward to Lys67 and Asp128/Glu171. European Journal of Medicinal Chemistry, 257, 115514. https://doi.org/10.1016/j.ejmech.2023.115514

Chicago

Xiang, Ruiqing, Mingzhu Lu, Tianze Wu, Chengbin Yang, Yu Jia, Xiaofeng Liu, Mingli Deng, et al. 2023. “Discovery of a High Potent PIM Kinase Inhibitor for Acute Myeloid Leukemia Based on N-Pyridinyl Amide Scaffold by Optimizing the Fragments toward to Lys67 and Asp128/Glu171.” European Journal of Medicinal Chemistry 257 (September): 115514. doi:10.1016/j.ejmech.2023.115514.